Singapore markets close in 7 hours 15 minutes
Straits Times Index
3,332.15 +2.06 (+0.06%) Nikkei
38,825.00 -30.37 (-0.08%) Hang Seng
18,659.42 -161.74 (-0.86%) FTSE 100
8,254.18 -63.41 (-0.76%) Bitcoin USD
68,522.58 -826.20 (-1.19%) CMC Crypto 200
1,481.10 -15.36 (-1.03%)
MRK Jun 2024 135.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 03:48PM EDT. Market open.
| Previous close | 0.4500 |
| Open | 0.4000 |
| Bid | 0.1200 |
| Ask | 0.1500 |
| Strike | 135.00 |
| Expiry date | 2024-06-21 |
| Day's range | 0.1100 - 0.4000 |
| Contract range | N/A |
| Volume | |
| Open interest | 14.21k |
Business WireMerck Announces Third-Quarter 2024 Dividend
RAHWAY, N.J., May 28, 2024--Merck Announces Third-Quarter 2024 Dividend
BenzingaMerck's Multi-Billion Cancer Drug Keytruda Aces Late-Stage Breast Cancer Study (UPDATED)
Editor’s Note: The title of the story is updated to correct the reference to ‘Breast’ cancer instead of ‘Lung’ cancer. Tuesday, Merck & Co Inc (NYSE:MRK) released topline data from hase 3 KEYNOTE-522 trial of Keytruda in high-risk early-stage triple-negative breast cancer (TNBC). The study evaluated Keytruda in combination with chemotherapy as a pre-operative (neoadjuvant) treatment and then continuing as a single agent after surgery (adjuvant). The study met its overall survival (OS) endpoint.
Simply Wall St.Is Merck & Co., Inc.'s (NYSE:MRK) Recent Performance Underpinned By Weak Financials?
Merck (NYSE:MRK) has had a rough month with its share price down 1.3%. To decide if this trend could continue, we...
© 2024 Yahoo. All rights reserved.